MedTrace Logo

Electromagnetic Therapy for Cervicogenic Dysphagia

NCT07765043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-08-14

No results posted yet for this study

Summary

Cervicogenic dysphagia (CD) is a swallowing disorder in patients with cervicogenic pathology. Pulsed electromagnetic therapy (PEMT) is a widely utilized therapeutic modality. Objective: To investigate the effects of PEMT on swallowing function (SF) and dysphagia handicapping effects in patients with CD. Methods: 40 volunteer participants (50-60 years old) with CD and cervical spondylosis were randomly and equally assigned to the study group (PEMT+swallowing resistance training program "SRTP") and control group (placebo PEMT+SRTP). Intervention: All participants received 3 sessions of SRTP (resisted chin tuck-in and resisted swallowing exercises) and 2 PEMT sessions (20 minutes of 20 Hz low frequency, 0.8 milli Tesla low intensity) per week for 8 weeks. Outcome Measures: The SF was evaluated using the swallow difficulty questionnaire "SDQ", and the dysphagia handicapping effects were evaluated using the dysphagia handicap index (DHI) pre-and post-study. Statistical analysis: Within-group comparisons were done using a paired t-test, and the between-group differences were examined using two-way ANOVA; a significant value was set at P\<0.05.

Conditions

  • Swallowing Disorder.Other Specified

Interventions

BEHAVIORAL

The pulsed electromagnetic field treatment program plus the swallowing resistance training program

The pulsed electromagnetic field treatment program plus the swallowing resistance training program

BEHAVIORAL

The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

The placebo pulsed electromagnetic field treatment program plus the swallowing resistance training program

Sponsors & Collaborators

  • Umm Al-Qura University

    lead OTHER

Principal Investigators

  • ASHRAF AM ABDELAAL, Ph.D. · Umm Al-Qura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-03-20
Completion
2026-05-25

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07765043 on ClinicalTrials.gov